Vitamin D: prescription audit in tertiary health care centre

Authors

  • Amruta V. Dashputra Department of Pharmacology, NKP Salve Institute of Medical Sciences, Nagpur, Maharashtra, India
  • Rupesh T. Badwaik Department of Pharmacology, NKP Salve Institute of Medical Sciences, Nagpur, Maharashtra, India
  • Archana S. Borker Department of Pharmacology, NKP Salve Institute of Medical Sciences, Nagpur, Maharashtra, India
  • Amit P. Date Department of Pharmacology, NKP Salve Institute of Medical Sciences, Nagpur, Maharashtra, India
  • Priyanka Survase Department of Pharmacology, NKP Salve Institute of Medical Sciences, Nagpur, Maharashtra, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20173737

Keywords:

Calcium, Data collection, Vitamin-D deficiency

Abstract

Background: Vitamin-D is critically important for development, growth and maintenance of health of human being. Many evidences show association between vit-D deficiency and several serious health conditions. Data collection on use of drugs is being obtained with the aim of optimizing drug therapy. So far till date only few studies about prescription pattern of vit-D have been found. Hence it is very important to do audit of prescriptions of vit-D. The aim of the study is to provide concise and updated information about the use of vit-D in tertiary care hospital and to record demographic details of patients.

Methods: After ethical approval, this cross sectional study was conducted at tertiary health centre. Patient and drug data (name of drug, dose, dosage form and route of administration) was collected from the patient’s prescriptions in OPD.

Results: Highest prescriptions of vit-D were found in orthopedic department (22% of total prescriptions of that department). Prescribing percentage of vit-D in medicine department was 4.6%, dermatology 1.5% and in psychiatry 0.8% of total prescriptions. Prescriptions of vit-D in combination with calcium were found in orthopedics (52%), medicine (7%) and obstetrics and gynecology (10%) departments.

Conclusions: Highest prescriptions of vit-D alone and with calcium found in orthopedic department. Periodic therapeutic audit is necessary to rationalise the use of vit D.

References

Joshi SR. Vitamin D paradox in plenty sunshine in rural India- An emerging threat. Editorial JAPI. Oct 2008;56:749-52.

Goswami R, Kochupilli N, Gupta N, Goswami D, Singh N, Dudha A. Presence of 25(OH)D deficiency in a rural north Indian village despite abundant sunshine. Journal Association Physician India. 2008:56:755-7.

Holick MF. Vitamin D status: measurement, interpretation and clinical application. Ann epidemiol 2009 Feb;19(2):73-8.

WHO. The selection of essential drugs. WHO Technical report. 1977;Serial No. 615:36.

Gama H. Drug Utilization Studies. Arquivos DE MEDICINA. WHO. 2008;22(2/3):67-74.

WHO Collaborating Centre for Drug Statistics Methodology. International language for drug utilization research. Available at: https://www.whocc.no/atc-ddd-index Retrieved on 16 Nov 2016.

Bringhurst FR, Demay MB, Krane, SM, Kronenberg HM. Bone and mineral metabolism in health and disease. In Harrisons Principles of internal medicine Editor Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscalzo J. 19th Edition; 2015:2454-2465.

Goswami R, Mishra SK, Kochupillai N. Prevalence and potential significance of vitamin D deficiency in AsianIndians. Indian J Med Rev 2008 March;127(3):229-38.

Ozfirat Z, Chowdhury TA. Vit D deficiency and type 2 diabetes. Postgrad Med J. 2010;86:18-25.

Kitaguchi T, Oya M, Wada Y, Tsuboi T, Miyawaki A. Extracellular calcium influx activates adenylate cyclase 1 and potentiates insulin secretion in MIN6 cells. Biochem J. 2013;450(2):365-73.

Wolden-Kiek H, Overbergh L, Christeen HT, Brusgard K, Chantal M. Vitamin D and diabetes: Its importance for beta cell and immune function. Mol cell Endocrinol. 2011;347:106-20.

Eduardo C, Chages A, Borges MC, Martini LA, Rogero MM. Focus on vitamin D, inflammation and type 2 diabetes. Nutrients. 2012;4(1):52-67.

Baz- Hecht M, Goldfine AB. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes, 2010;17:113-9.

Binkley N, Ramamurthy R, Krueger D. Low vitamin D status: definition, prevention, consequences and correction. Endocrinal Metab clin North Am. 2010;39:287-301.

Lazear J, Kapustin J. Vitamin D deficiency and type 2 diabetes: A retrospective review. The Journal for Nurse Practitioners-JNP. 2014;10(3):175-82.

Guidelines for the prescribing of Vitamin D in Adults. NHS Cumbria. Clinical commission group. July 2013:1-13.

Satoskar RS, Bhandarkar SD, Rege NN. In Pharmacology and Pharmacotherapeutics, 19th Edition 2005:158-180.

Friedman PA. Agents affecting mineral Ion, Homeostasis and Bone turnover. In Brutan LL, Chabner BA, Knollmann BC, eds Goodman & Gillman’s Pharmacological Basis of Therapeutics. 12th Edition; New York, NY: McGraw Hill; 2011:1275-1306.

Downloads

Published

2017-08-22

How to Cite

Dashputra, A. V., Badwaik, R. T., Borker, A. S., Date, A. P., & Survase, P. (2017). Vitamin D: prescription audit in tertiary health care centre. International Journal of Basic & Clinical Pharmacology, 6(9), 2163–2166. https://doi.org/10.18203/2319-2003.ijbcp20173737

Issue

Section

Original Research Articles